Pulling SEC filings + quote and writing the call…
| Fiscal year | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $16.1M | $23.2M | $17.1M | $22.5M | $28.1M | $33.6M |
| Revenue growth | — | 44.5% | -26.3% | 31.4% | 24.6% | 19.7% |
| Operating income | -$30.5M | -$47.2M | -$63.2M | -$56.6M | -$49.9M | -$47.4M |
| Operating margin | -190.0% | -203.3% | -369.0% | -251.2% | -178.0% | -141.1% |
| Net income | -$37.1M | -$73.5M | -$60.8M | -$52.5M | -$46.9M | -$47.1M |
| Net margin | -230.6% | -316.5% | -354.9% | -233.0% | -167.2% | -140.3% |
| EPS (diluted) | -$126.11 | -$3.94 | -$1.43 | -$1.22 | -$1.08 | -$1.05 |
| Fiscal year | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$31.0M | -$55.0M | -$58.5M | -$45.1M | -$44.2M | -$31.1M |
| Capital expenditures | $690K | $3.22M | $6.74M | $1.84M | $1.36M | $850K |
| Free cash flow | -$31.7M | -$58.2M | -$65.3M | -$46.9M | -$45.5M | -$31.9M |
| Fiscal year | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $30.1M | $178M | $27.1M | $24.3M | $16.9M | $20.0M |
| Total assets | $70.0M | $241M | $191M | $143M | $98.2M | $74.9M |
| Total liabilities | $45.2M | $20.2M | $26.5M | $25.5M | $22.8M | $41.6M |
| Long-term debt | $24.8M | $0.00 | $0.00 | — | $0.00 | $18.9M |
| Shareholders' equity | -$127M | $221M | $164M | $118M | $75.4M | $33.2M |
| Retained earnings | -$242M | -$315M | -$376M | -$428M | -$475M | -$522M |
| Shares (wtd avg diluted) | 359K | 19.8M | 42.5M | 43.0M | 43.6M | 44.7M |
Every figure is extracted from RAPID MICRO BIOSYSTEMS, INC.’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.